The enhanced vascular endothelial growth factor (VEGF) pathway plays an important role in the survival and proliferation of cancer cells with TP53 mutations13,14 and thus represents a potential therapeutic target in TP53 mutant cancers. Here, VEGFA is linked to cancer.